Strategy Starts at Discovery: Using QSP to Choose the Right Indication, the Right Asset, and the Right Path to First-in-Human
Watch the webinar to learn how QSP and a model-informed target product profile guide indication,…
Danielle PillsburyOctober 9, 2026
Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV
Explore population PK modeling of dolutegravir in plasma and cerebrospinal fluid to characterize CNS penetration…
CertaraOctober 5, 2026
Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma
Explore a simultaneous population PK/PD model characterizing the dynamic relationships between belantamab mafodotin, sBCMA, and…
CertaraOctober 5, 2026
CODEX Clinical Outcomes Databases Hidradenitis Suppurativa (HS)
Explore Certara's CODEX Hidradenitis Suppurativa database ~43 studies with key efficiency and safety endpoints (HiSCR50,…
Danielle PillsburySeptember 25, 2026
CODEX Clinical Outcomes Databases Chronic Heart Failure (CHF)
Explore Certara's CODEX Chronic Heart Failure database ~200 studies with key efficiency and safety endpoints…
CertaraSeptember 25, 2026
